capecitabine,temozolomide
roche
['pancreatic']
research led by shows patients with pancreatic neuroendocrine tumors #nets treated with combo of capecitabine &amp; temozolomide had longer progression-free survival than those only treated w temozolomide. #asco22 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.